Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rother

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Human Gene Therapy|March 20, 1996
Retroviral vector producer cell killing in human serum is mediated by natural antibody and complement: strategies for evading the humoral immune responseS A Rollins, C W Birks, E Setter, et al.
Nature Biotechnology|November 9, 2007
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuriaRussell P Rother, Scott A Rollins, Christopher F Mojcik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2007
Anti-C5 antibody treatment ameliorates weakness in experimentally acquired myasthenia gravisYuefang Zhou, Bendi Gong, Feng Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 1997
Alteration of glycosylation renders HIV sensitive to inactivation by normal human serumD J Reed, X Lin, T D Thomas, et al.
Transplantation|June 3, 2000
Role of porcine P-selectin in complement-dependent adhesion of human leukocytes to porcine endothelial cellsS A Rollins, K K Johnson, L Li, et al.
The British Journal of Surgery|August 4, 2005
C5 complement inhibition attenuates shock and acute lung injury in an experimental model of ruptured abdominal aortic aneurysmD W Harkin, C D Marron, R P Rother, et al.
Transplantation|December 15, 1995
Porcine vascular cell adhesion molecule (VCAM) mediates endothelial cell adhesion to human T cells. Development of blocking antibodies specific for porcine VCAMJ P Mueller, M J Evans, R Cofiell, et al.
Haematologica|February 11, 2010
Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonizationAnita Hill, Russell P Rother, Louise Arnold, et al.
Blood|December 3, 2003
A novel mechanism of complement-independent clearance of red cells deficient in glycosyl phosphatidylinositol-linked proteinsMarek Jasinski, Panagiotis Pantazopoulos, Russell P Rother, et al.
Transplantation|May 10, 2005
Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporineHao Wang, Jifu Jiang, Weihua Liu, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Human Gene Therapy|March 20, 1996
Retroviral vector producer cell killing in human serum is mediated by natural antibody and complement: strategies for evading the humoral immune responseS A Rollins, C W Birks, E Setter, et al.
Nature Biotechnology|November 9, 2007
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuriaRussell P Rother, Scott A Rollins, Christopher F Mojcik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2007
Anti-C5 antibody treatment ameliorates weakness in experimentally acquired myasthenia gravisYuefang Zhou, Bendi Gong, Feng Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 1997
Alteration of glycosylation renders HIV sensitive to inactivation by normal human serumD J Reed, X Lin, T D Thomas, et al.
Transplantation|June 3, 2000
Role of porcine P-selectin in complement-dependent adhesion of human leukocytes to porcine endothelial cellsS A Rollins, K K Johnson, L Li, et al.
The British Journal of Surgery|August 4, 2005
C5 complement inhibition attenuates shock and acute lung injury in an experimental model of ruptured abdominal aortic aneurysmD W Harkin, C D Marron, R P Rother, et al.
Transplantation|December 15, 1995
Porcine vascular cell adhesion molecule (VCAM) mediates endothelial cell adhesion to human T cells. Development of blocking antibodies specific for porcine VCAMJ P Mueller, M J Evans, R Cofiell, et al.
Haematologica|February 11, 2010
Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonizationAnita Hill, Russell P Rother, Louise Arnold, et al.
Blood|December 3, 2003
A novel mechanism of complement-independent clearance of red cells deficient in glycosyl phosphatidylinositol-linked proteinsMarek Jasinski, Panagiotis Pantazopoulos, Russell P Rother, et al.
Transplantation|May 10, 2005
Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporineHao Wang, Jifu Jiang, Weihua Liu, et al.
Pageof 13